grant

Cilia disassembly and dysfunction in malformations of cortical development

Organization YALE UNIVERSITYLocation NEW HAVEN, UNITED STATESPosted 20 Mar 2026Deadline 30 Nov 2030
NIHUS FederalResearch GrantFY2026ARH12AutoregulationBiologyBourneville DiseaseBourneville PhakomatosisBourneville syndromeBourneville-Brissaud diseaseBourneville-Pringle syndromeBrainBrain Nervous SystemBreslowBreslow ThicknessCRISPR activationCRISPR activatorCRISPR based activationCRISPR editing screenCRISPR gene activationCRISPR screenCRISPR transcription activationCRISPR transcriptional activationCRISPR-Cas-9-mediated gene activationCRISPR-based gene activationCRISPR-based screenCRISPR-dCAS9 ActivatorCRISPR-mediated transcriptional activationCRISPR/CAS9 activationCRISPR/CAS9 gene activationCRISPR/Cas9 screenCRISPR/dCas9 activationCRISPR/dCas9-based transcriptional activationCRISPRaCalciumCell BodyCell Communication and SignalingCell ComponentsCell SignalingCell StructureCellsCellular StructuresCharacteristicsCiliaCollaborationsComplexCortical DysplasiaCortical MalformationCultured CellsDNA mutationDataDefectDevelopmentDiseaseDisorderDrug resistanceDrugsDysfunctionEncephalonEpilepsyEpileptic SeizuresEpilepticsEpiloiaEventExhibitsFK506 Binding Protein 12-Rapamycin Associated Protein 1FKBP12 Rapamycin Complex Associated Protein 1FRAP1FRAP1 geneFRAP2Functional disorderGene variantGenesGeneticGenetic ChangeGenetic HeterogeneityGenetic defectGenetic mutationGenetic studyHamartinHomeostasisHyperactivityImpairmentIntracellular Communication and SignalingMechanistic Target of RapamycinMediatingMediatorMedicationMiceMice MammalsModelingMosaicismMurineMusMutateMutationNerve CellsNerve UnitNervous System DiseasesNervous System DisorderNeural CellNeurocyteNeurodevelopmental DisorderNeurologic DisordersNeurological Development DisorderNeurological DisordersNeuronsOperative ProceduresOperative Surgical ProceduresOverlapping GenesPathogenesisPathogenicityPathologicPathologyPathway interactionsPatientsPharmaceutical PreparationsPhenotypePhysiological HomeostasisPhysiopathologyPopulationPringle diseaseRAFT1RHOARHOA geneRHOH12RegulationReportingRho12RoleSeizure DisorderSeizuresSignal TransductionSignal Transduction SystemsSignalingSomatic MutationSurgicalSurgical InterventionsSurgical ProcedureSynapsesSynapticTSC1TSC1 geneTSC2TSC2 geneTSC4TSC4 GeneTestingTherapeuticTuberinTuberous SclerosisVariantVariationWorkactivating CRISPR technologyadenoma sebaceumallelic variantbasal bodybasebasesbiological signal transductioncerebral sclerosisciliopathyclass developmentclustered regularly interspaced short palindromic repeats screencourse developmentcourse material developmentdevelopmentaldiagnostic tooldrug resistantdrug/agentepilepsiaepileptogenicepiploiafunctional genomicsgenetic etiologygenetic mechanism of diseasegenetic variantgenome mutationgenome scalegenome-widegenomewidegenomic varianthereditary multiple system hamartomatosisimprovedin vivoinsightkinetosomemTORmalformation in cortical developmentmammalian target of rapamycinmosaic diseasesmosaic disordersneural circuitneural circuitryneurinomatosis centralisneurocircuitryneurodevelopmental diseaseneurogeneticsneurological diseaseneuromatosis universalisneuron developmentneuronalneuronal developmentneurospongioblastosis diffusanew drug targetnew drug treatmentsnew druggable targetnew drugsnew pharmacological therapeuticnew pharmacotherapy targetnew therapeutic approachnew therapeutic interventionnew therapeutic strategiesnew therapeutic targetnew therapeuticsnew therapynew therapy approachesnew therapy targetnew treatment approachnew treatment strategynext generation therapeuticsnovelnovel drug targetnovel drug treatmentsnovel druggable targetnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel pharmacotherapy targetnovel therapeutic approachnovel therapeutic interventionnovel therapeutic strategiesnovel therapeutic targetnovel therapeuticsnovel therapynovel therapy approachnovel therapy targetpathophysiologypathwayphacomatosisresistance to Drugresistant to Drugrestorationsclerosis tuberosascreeningscreeningssocial rolesomatic variantspongioblastosis circumscriptasurgerysynapsesynaptic circuitsynaptic circuitrytuberose sclerosistuberous sclerosis 1tuberous sclerosis complex
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY
Malformations of cortical development (MCDs) are neurological disorders characterized by altered organization

and function of cortical neurons, often leading to intractable epileptic seizures. Somatic mutations in more than

60 genes have been found in MCDs, with pathogenic variants causing focal impairment of cortical function.…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Cilia disassembly and dysfunction in malformations of cortical development — YALE UNIVERSITY | UNITED STATES | Mar 2026 | Dev Procure